Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Universität des Saarlandes
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University